Literature DB >> 20374400

Improving anticoagulation control in hospitalized elderly patients on warfarin.

Isabelle Gouin-Thibault1, Camille Levy, Eric Pautas, Jean-Pierre Cambus, Ludovic Drouet, Isabelle Mahé, Claire Bal Dit Sollier, Marie-Hélène Horellou, Jean-Louis Golmard, Virginie Siguret.   

Abstract

OBJECTIVES: To determine the effect of patient characteristics and of specific guidelines that were developed for managing warfarin therapy in older adults and included in an in-house computer program on anticoagulation quality.
DESIGN: Thirteen-month observational study.
SETTING: Acute care, extended care, and rehabilitation geriatric wards of a teaching hospital in Paris, France. PARTICIPANTS: Hospitalized patients (N=307, mean age 86.1 +/- 6.1) treated with warfarin with a therapeutic international normalized ratio range of 2.0 to 3.0. INTERVENTION: Patients were assigned according to care unit to the computer-generated dosing group (CGD) or the standard management group (SM; usual physician-based care). MEASUREMENTS: Relationships between anticoagulation quality criteria and covariates (age, sex, warfarin indication, treatment phase, follow-up duration, model of care).
RESULTS: According to multivariate analysis, only model of care and follow-up duration independently influenced anticoagulation control; the proportion of time within therapeutic INR range 2.0 to 3.0 was significantly greater in the CGD group than in the SM group (59% vs 48%, P=.004). When a wider INR range was analyzed (1.8-3.2), the proportion of time within range was 73% versus 64% (P=.006). Use of the computer was associated with fewer days with INRs greater than 3, a smaller percentage of INRs of 4 or greater, a longer time to the first INR of 4.0 or greater, and a smaller mean number of INRs per month than SM (all P<.01).
CONCLUSION: Initiation regimen and long-term rules that have specifically been developed and included in a computerized dosage program improve quality of anticoagulation in elderly inpatients, allowing them to benefit from a quality of care as high as that of younger ambulatory patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20374400     DOI: 10.1111/j.1532-5415.2009.02675.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  9 in total

1.  Inpatient warfarin management: pharmacist management using a detailed dosing protocol.

Authors:  Nancy L Dawson; Ivan E Porter; Dusko Klipa; William R Bamlet; Mary Ann Hedges; Michael J Maniaci; Jason Persoff; Archana Roy; Alden V Patel
Journal:  J Thromb Thrombolysis       Date:  2012-02       Impact factor: 2.300

Review 2.  Health information technologies in geriatrics and gerontology: a mixed systematic review.

Authors:  Isabelle Vedel; Saeed Akhlaghpour; Isaac Vaghefi; Howard Bergman; Liette Lapointe
Journal:  J Am Med Inform Assoc       Date:  2013-05-10       Impact factor: 4.497

Review 3.  Optimizing the use of anticoagulants (heparins and oral anticoagulants) in the elderly.

Authors:  Virginie Siguret; Isabelle Gouin-Thibault; Pascale Gaussem; Eric Pautas
Journal:  Drugs Aging       Date:  2013-09       Impact factor: 3.923

Review 4.  Year in review: medication mishaps in the elderly.

Authors:  Emily P Peron; Zachary A Marcum; Richard Boyce; Joseph T Hanlon; Steven M Handler
Journal:  Am J Geriatr Pharmacother       Date:  2011-02

Review 5.  Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation.

Authors:  Danielle E Clarkesmith; Helen M Pattison; Phyo H Khaing; Deirdre A Lane
Journal:  Cochrane Database Syst Rev       Date:  2017-04-05

6.  Effects of computer-assisted oral anticoagulant therapy.

Authors:  Rune Skovgaard Rasmussen; Pernille Corell; Poul Madsen; Karsten Overgaard
Journal:  Thromb J       Date:  2012-08-30

7.  The case for an elderly targeted stroke management.

Authors:  Osvaldo Fustinoni
Journal:  Front Neurol       Date:  2011-12-30       Impact factor: 4.003

8.  Computer Algorithm-Based Hydroxyurea Dosing Facilitates Titration to Maximum Tolerated Dose in Sickle Cell Anemia.

Authors:  Mahogany Oldham; Anna Conrey; Corinne Pittman; Cameron Fisher; Simone Hargrett; Kamille West; Mary Jackson; Staci Martin; Matthew M Hsieh; Neal Jeffries; Mihailo Kaplarevic; Dachelle Johnson; Purevdorj Olkhanud; Courtney D Fitzhugh
Journal:  J Clin Pharmacol       Date:  2020-07-16       Impact factor: 2.860

9.  Improving inpatient warfarin therapy safety using a pharmacist-managed protocol.

Authors:  Paul R Daniels; Dennis M Manning; James P Moriarty; Juliane Bingener-Casey; Narith N Ou; John G O'Meara; Daniel L Roellinger; James M Naessens
Journal:  BMJ Open Qual       Date:  2018-04-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.